Identification of B-cell Epitope Regions in Cell Surface Proteins of Streptococcus pneumoniae Serotype 19F Using Bioinformatic Tools
Keywords:
B-cell Epitopes, Pneumococcal serotypes, Pneumococcal vaccines, Streptococcus pneumoniae.Abstract
Pneumococcal conjugate vaccines (PCVs) were developed through chemical coupling of polysaccharide capsules of pneumococci to immunogenic carrier proteins and World Health Organization recommends inclusion of these vaccines in national immunization programs for children. However, the PCVs implementation in developing countries is prevented by the high vaccine manufacturing costs. This issue can be resolved by construction of protein based vaccines against pneumococci. We already identified three pneumococcal surface proteins including autolysin, zinc binding lipoprotein (ZBL), and plasmid stabilization protein (PSP) as appropriate protein candidates for eliciting protection against S. pneumoniae serotype 19F. The protein protective antigenicity and the absence of autoimmunity induction were used as selection criteria. However, regarding the necessity of the antibody response for protection against pneumococci, analysis of protective B-cell epitopes of these proteins is required to elucidate their usefulness in new vaccine formulations. In the present study, therefore, we aim to identify protective B-cell epitope regions of these proteins via widely used bioinformatic tools. Both of the Bepipred and BCPreds programs were used for identification of linear B-cell epitopes. The conformational B-cell epitopes were predicted using the CBTope program. The immunoprotective abilities of epitopes were evaluated using VaxiJen. We determined the linear B-cell epitope regions, which were predicted by both Bepipred and BCPreds and have common amino acids with conformational B-cell epitopes. Our results showed that all of the three studied proteins included such protective overlapped linear B-cell epitope regions. However, a truncated form of PSP had the greatest number of the protective overlapped B-cell epitope regions.
Moreover, the most probable protective epitope region resides in this protein and this epitope region is completely conserved in PSPs of serotype 19F pneumococcal strains. Therefore, the truncated PSP was an appropriate candidate for development of protein based vaccines against S. pneumoniae serotype 19F.
References
[2] WHO. “Pneumococcal vaccines, WHO position paper.” Wkly Epidemiol Rec. vol. 87. pp. 129-144. Apr. 2012.
[3] H. L. Johnson, M. Deloria-Knoll, O. S. Levine, S. K. Stoszek, L. F. Hance, R. Reithinger, et al. “Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.” PLoS Med. vol. 7. pp. 1-13. Oct. 2010.
[4] T. J. Foster, J. A. Geoghegan, V. K. Ganesh, and M. Hook. “Adhesion, invasion and evasion: the many functions of surface proteins of Staphylococcus aureus.” Nature Rev Microbiol. vol. 12. pp. 49-62. Dec. 2014.
[5] S. Bergmann and S. Hammerschmidt. “Versatility of pneumococcal surface proteins.” Microbiol. vol. 152. pp. 295-303. Feb. 2006.
[6] S. Tarahomjoo. “Bioinformatic analysis of surface proteins of Streptococcus pneumoniae serotype 19F for identification of vaccine candidates.” Am J Microbiol Research. vol. 2. pp. 174-177. Oct. 2014.
[7] S. Tarahomjoo. “Recent approaches in vaccine development against Streptococcus pneumonia.” J Mol Microbiol Biotechnol. vol. 24. pp. 215-227. August 2014.
[8] D. F. Kelly and R. Rappuoli. Hot topics in infection and immunity in children II. New York: Springer. 2005. pp. 217-223.
[9] I. A. Doytchinova and D. R. Flower. “Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines.” Open Vaccine J. vol. 1. pp. 22-26. Sep. 2008.
[10] J. Novotny,. M. Handschumacher, E. Haber, R. E. Bruccoleri, W. B. Carlson, D. W. Fanning, et al. “Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains).” Proc Natl Acad Sci USA vol. 83. pp. 226-230. Jan. 1986.
[11] L. Quijada, M. J. Requema. M. Soto, L. C. Gomez, F. Guzman, M. E. Patarroyo, et al. “Mapping of the linear antigenic determinants of the Leishmania infantum Hsp 70 recognized by leishmaniasis sera.” Immunol Lett. vol. 52. pp. 73-79. Sep. 1996.
[12] A. R. Faria, M. M. Costa, M. S. Giusta, G. G. Jr, M. L. O. Penido, R. T. Gazzinelli, et al. “High throughput analysis of synthetic peptides for the immunodiagnosis of canine visceral leishmaniasis.” PLos Negl Trop dis. vol. 5. pp. 1-9. Sep. 2011.
[13] H. L. Atilano, P. M. Pereira, F. Vaz et al. “Bacterial autolysins trim cell surface peptidoglycan to prevent detection by the Drosophila innate immune system.” eLife, vol. 3, pp. 1-23, Apr. 2014.
[14] R. Gabbianelli, R. Scotti, S. Ammendola, P. Petrarca, L. Nicolini and A. Battistoni. “Role of ZnuABC and ZinT in Escherichia coli O157: H7 zinc acquisition and interaction with epithelial cells.” BMC Microbiol. vol. 11. pp. 1-11. Feb. 2011.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
